Basic Information
| LncRNA/CircRNA Name | LINC02163 |
| Synonyms | NA |
| Region | GRCh38_5:104079911-104105,403 |
| Ensemble | ENSG00000251026 |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | qPCR, Western blot, etc. |
| Sample | Gastric cancer cell lines, normal gastric epithelial cell line. |
| Expression Pattern | up-regulated |
| Function Description | To the best of our knowledge, our findings provided the first evidence that LINC02163 functioned as an oncogene in GC. LINC02163 may be a candidate prognostic biomarker and a target for new therapies in GC patients.GC patients with high LINC02163 expression had shorter disease-free survival and the over-all survival rate than those with low LINC02163 expression.The miR-593-3p/FOXK1 axis mediated LINC02163?? effect on GC. |
| Pubmed ID | 29893595 |
| Year | 2018 |
| Title | LINC02163 regulates growth and epithelial-to-mesenchymal transition phenotype via miR-593-3p/FOXK1 axis in gastric cancer cells. |
External Links
| Links for LINC02163 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |